Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA and iMRI for Glioblastoma Resection
NCT01575275Phase 2Terminated
- Start
- May 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in glioblastoma (GBM), Gliosarcoma (GS). Started May 2012; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT01575275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575275.